Chris Pazdan Joins KORU Medical as VP of Quality Assurance, Regulatory Affairs

Chris Pazdan has become the newest member of KORU Medical Systems’ executive team.

Leveraging his more than 16 years of relevant experience, Pazdan is the company’s new vice president of Quality Assurance and Regulatory Affairs. He is responsible for all quality assurance and regulatory affairs and will help the company build out its Quality Management System and a regulatory strategy to meet evolving global standards.
 
“Chris has the right mix of strategic, operational, and corporate quality and regulatory skills to bring to this role at KORU Medical,” said Linda Tharby, CEO. “His proven track record of developing and leading strategy, a focus on execution and building strong teams will be a valuable asset to KORU Medical as we advance our quality capabilities to meet the needs of our biopharmaceutical customers and support our growth strategy.
 
Pazdan most recently spent more than three years at Hillrom working as vice president, Quality Assurance, leading all quality functions for the largest manufacturing division. He also served as vice president, Quality Assurance and Regulatory Affairs, where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Before his tenure at Hillrom, Pazdan worked at Abbott Laboratories, Becton Dickinson and Company, Wockhardt, and Rexam Pharma.

Pazdan earned his bachelor’s degree in engineering from the University of Illinois at Urbana-Champaign. He is an ASQ Certified Six Sigma Black Belt, ASQ Certified Quality engineer, and an ASQ Certified Quality auditor.
 
KORU Medical Systems develops, manufactures, and commercializes specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings.